187 related articles for article (PubMed ID: 25251578)
1. The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.
Fang F; Sveinsson O; Thormar G; Granqvist M; Askling J; Lundberg IE; Ye W; Hammarström L; Pirskanen R; Piehl F
J Intern Med; 2015 May; 277(5):594-604. PubMed ID: 25251578
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
3. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
4. HLA-B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathy.
Andresdottir MB; Haasnoot GW; Persijn GG; Claas FH
Clin Transplant; 2009; 23(5):660-5. PubMed ID: 19674013
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis and scleroderma.
Bhalla R; Swedler WI; Lazarevic MB; Ajmani HS; Skosey JL
J Rheumatol; 1993 Aug; 20(8):1409-10. PubMed ID: 8230029
[TBL] [Abstract][Full Text] [Related]
7. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune disease in families with multiple sclerosis: a population-based study.
Ramagopalan SV; Dyment DA; Valdar W; Herrera BM; Criscuoli M; Yee IM; Sadovnick AD; Ebers GC;
Lancet Neurol; 2007 Jul; 6(7):604-10. PubMed ID: 17560172
[TBL] [Abstract][Full Text] [Related]
9. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies.
Lindsey JW; Albers GW; Steinman L
Ann Neurol; 1992 Sep; 32(3):407-9. PubMed ID: 1416813
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune-associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4 complement gene copy numbers and HSP-2 1267A/G.
Kaur G; Kumar N; Szilagyi A; Blasko B; Fust G; Rajczy K; Pozsonyi E; Hosso A; Petranyi G; Tandon N; Mehra N
Hum Immunol; 2008 Sep; 69(9):580-7. PubMed ID: 18657583
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis and tumor necrosis factor beta polymorphisms: linkage disequilibrium but no association beyond HLA-B8.
Manz MG; Melms A; Sommer N; Müller CA
J Neuroimmunol; 1998 Oct; 90(2):187-91. PubMed ID: 9817446
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.
Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G
J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism.
Mäkelä S; Mustonen J; Ala-Houhala I; Hurme M; Partanen J; Vapalahti O; Vaheri A; Pasternack A
J Infect Dis; 2002 Sep; 186(6):843-6. PubMed ID: 12198621
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.
Scherbaum WA; Schumm F; Maisch B; Müller C; Fateh-Moghadam A; Flüchter SH; Seif FJ; Bottazzo GF; Berg PA
Klin Wochenschr; 1983 May; 61(10):509-15. PubMed ID: 6876683
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
Wiencke K; Spurkland A; Schrumpf E; Boberg KM
Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the disease-associated complement C4 gene from the HLA-A1, B8, DR3 haplotype.
Ulgiati D; Abraham LJ
Exp Clin Immunogenet; 1996; 13(1):43-54. PubMed ID: 8854088
[TBL] [Abstract][Full Text] [Related]
17. Genetic factors in myasthenia gravis: a family study.
Kerzin-Storrar L; Metcalfe RA; Dyer PA; Kowalska G; Ferguson I; Harris R
Neurology; 1988 Jan; 38(1):38-42. PubMed ID: 3336461
[TBL] [Abstract][Full Text] [Related]
18. Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8,DR3 phenotype.
Colucci AT; Di Lorenzo G; Ingrassia A; Crescimanno G; Modica MA; Candore G; Caruso C
Exp Clin Immunogenet; 1992; 9(2):72-9. PubMed ID: 1489552
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.
Landgren O; Engels EA; Pfeiffer RM; Gridley G; Mellemkjaer L; Olsen JH; Kerstann KF; Wheeler W; Hemminki K; Linet MS; Goldin LR
J Natl Cancer Inst; 2006 Sep; 98(18):1321-30. PubMed ID: 16985251
[TBL] [Abstract][Full Text] [Related]
20. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy.
Thorlacius S; Aarli JA; Riise T; Matre R; Johnsen HJ
Acta Neurol Scand; 1989 Oct; 80(4):290-5. PubMed ID: 2816285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
